Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Larimar Therapeutics, Inc.LRMR · Entity 5634 | Chief Financial Officer | January 26, 2026 | January 27, 2026 |
| ORASURE TECHNOLOGIES INCOSUR · Entity 6152 | Director | August 12, 2022 | August 16, 2022 |
| Societal CDMO, Inc.REPH · Entity 92137 | Chief Operating Officer | January 18, 2019 | February 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Larimar Therapeutics, Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,785 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 37,604 · Balance 215,785 F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.60 · Expires 2036-01-26 | Direct | 225,622 |
Reported balance
After 2026-01-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-26 · Grant · Acquired 225,622 · Balance 225,622 F2: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
ORASURE TECHNOLOGIES INC
Report date August 12, 2022 · Filed August 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,823 |
Reported balance
After 2022-08-12 transaction · row 1
1 source rowRow 1 · 2022-08-12 · Purchase · Acquired 12,000 · Balance 111,823 F1: Represents shares of Common Stock purchased in the open market on August 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock purchased in the open market on August 12, 2022.
Societal CDMO, Inc.
Report date January 18, 2019 · Filed February 19, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,855 |
Last balance in matching sequence
After 2019-01-18 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2019-01-18 · Grant · Acquired 14,464 · Balance 41,237 F1: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. Row 2 · 2019-01-18 · Exercise / conversion · Acquired 6,400 · Balance 47,637 F2: Restricted stock units convert into common stock on a one-for-one basis. Row 3 · 2019-01-18 · Tax withholding · Disposed 1,782 · Balance 45,855 F3: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.99 · Expires 2029-01-18 | Direct | 67,500 |
Reported balance
After 2019-01-18 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2019-01-18 · Grant · Acquired 67,500 · Balance 67,500 F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. F4: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,800 |
Reported balance
After 2019-01-18 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2019-01-18 · Exercise / conversion · Disposed 6,400 · Balance 12,800 F2: Restricted stock units convert into common stock on a one-for-one basis. F5: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units..
F4: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
F5: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2026 Filed Jan 27, 2026 17:03 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 225,622 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001193125-26-024824 · ownership.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,622 Underlying: Common Stock · 225,622 shares Expires 2036-01-26 F2 · derivative.exercise_date: The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 17:03 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantCommon Stock | 37,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-024824 · ownership.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,785 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:15 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 205,111 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001062993-25-001077 · form4.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,111 Underlying: Common Stock · 205,111 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 22, 2025 Filed Jan 24, 2025 16:15 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantCommon Stock | 34,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-001077 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,181 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:32 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 187,500 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001062993-24-001085 · form4.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2034-01-17 F2 · derivative.exercise_date: The option vests 25% on January 17, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:32 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-001085 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,996 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| May 17, 2023 Filed May 18, 2023 14:13 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | PurchaseCommon Stock | 5,000 | $3.73 | $18,631.50 |
DisclosureSEC source: 0001062993-23-011547 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,746 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.71 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:16 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0000899243-23-003735 · doc4.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-01-31 F2 · derivative.exercise_date: The option vests 25% on January 31, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:16 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantCommon Stock | 76,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003735 · doc4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,746 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 07:00 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | PurchaseCommon Stock | 31,746 | $3.15 | $99,999.90 |
DisclosureSEC source: 0001062993-22-019646 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 F1 · shares: Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:01 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | PurchaseCommon Stock | 12,000 | $4.49 | $53,916.00 |
DisclosureSEC source: 0001062993-22-018107 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,823 F1 · shares: Represents shares of Common Stock purchased in the open market on August 12, 2022. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:06 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 24,762 | $5.25 | $130,000.50 |
DisclosureSEC source: 0001062993-22-012896 · form4.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,823 F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2023. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:06 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 3,399 | $5.25 | $17,844.75 |
DisclosureSEC source: 0001062993-22-012896 · form4.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,061 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:28 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001062993-22-012308 · form4.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-10 F1 · derivative.exercise_date: The option vests 25% on May 10, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 19:19 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001062993-22-001320 · form4.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-01-18 F1 · derivative.exercise_date: The option vests 25% on January 18, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 19, 2021 20:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 13,559 | $9.59 | $129,996.91 |
DisclosureSEC source: 0001593968-21-001355 · primary_01.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,460 F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 16, 2022. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 2,041 | $9.50 | $19,391.95 |
DisclosureSEC source: 0001593968-21-001355 · primary_01.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,901 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 10:55 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $19.61 | $0.00 |
DisclosureSEC source: 0001192482-21-000074 · edgar.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2031-01-19 F1 · derivative.exercise_date: The option vests 25% on January 19, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 14:05 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (right to buy) · Derivative | 84,100 | $0.00 Strike: $11.90 | $0.00 |
DisclosureSEC source: 0001192482-20-000745 · edgar.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,100 Underlying: Common Stock · 84,100 shares Expires 2030-07-16 F1 · derivative.exercise_date: The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The Option vests 25% on July 16, 2021, with the remaining 75% vesting in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
| May 28, 2020 Filed Jun 5, 2020 20:04 UTC | Larimar Therapeutics, Inc. LRMR · Entity 5634 | GrantStock Option (Right to Buy) · Derivative | 60,479 | $0.00 Strike: $11.88 | $0.00 |
DisclosureSEC source: 0001192482-20-000435 · edgar.xml · derivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,479 Underlying: Common Stock · 60,479 shares Expires 2030-05-28 F1 · derivative.exercise_date: The option vests 25% on May 28, 2021, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2020 Filed May 19, 2020 20:37 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 8,143 | $15.97 | $130,003.00 |
DisclosureSEC source: 0001593968-20-001212 · primary_01.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,942 F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 17, 2021. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:37 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 3,843 | $16.04 | $61,642.10 |
DisclosureSEC source: 0001593968-20-001212 · primary_01.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,799 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 21, 2019 Filed May 22, 2019 21:06 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 15,330 | $8.48 | $129,998.40 |
DisclosureSEC source: 0001593968-19-001167 · primary_01.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,642 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:06 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 6,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000034 · edgar.xml · derivative · entry 5 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,800 Underlying: Common Stock · 6,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:06 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 60,592 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001192482-19-000034 · edgar.xml · derivative · entry 4 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,592 Underlying: Common Stock · 60,592 shares Expires 2029-01-18 F4 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:06 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,782 | $7.99 | $14,238.18 |
DisclosureSEC source: 0001192482-19-000034 · edgar.xml · nonDerivative · entry 3 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,063 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:06 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 6,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000034 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:06 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 12,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000034 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,445 F1 · shares: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 6,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000091 · edgar.xml · derivative · entry 5 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,800 Underlying: Common Stock · 6,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 67,500 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001192482-19-000091 · edgar.xml · derivative · entry 4 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2029-01-18 F6 · shares: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. F4 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,782 | $7.99 | $14,238.18 |
DisclosureSEC source: 0001192482-19-000091 · edgar.xml · nonDerivative · entry 3 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,855 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 6,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000091 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 14,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000091 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,237 F1 · shares: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F6 · shares: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:28 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,702 | $7.41 | $12,611.82 |
DisclosureSEC source: 0001192482-19-000020 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,773 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:19 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon stock | 1,578 | $15.98 | $25,208.55 |
DisclosureSEC source: 0001209784-18-000023 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,312 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:24 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon stock | 7,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209784-18-000018 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,890 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. F1 · price: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 6, 2019. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 20:25 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantNonqualified stock options · Derivative | 40,000 | Not disclosed Strike: $16.80 | Not disclosed |
DisclosureSEC source: 0001209784-18-000013 · edgar.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2028-04-01 F1 · kind: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors. F1 · price: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors. F1 · derivative.exercise_date: Grant of nonqualified stock options, vesting and exercisable on a monthly basis, over the 24 months immediately following the grant date. Vesting shall cease immediately if the named individual ceases to serve as a member of the Board of Directors. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 17:00 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 6,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000047 · edgar.xml · derivative · entry 3 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,200 Underlying: Common Stock · 6,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 17:00 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 2,020 | $8.89 | $17,957.80 |
DisclosureSEC source: 0001192482-18-000047 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,475 Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 17:00 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 6,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-18-000047 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:49 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0001192482-18-000017 · edgar.xml · derivative · entry 2 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-01-02 F2 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:49 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000017 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,095 F1 · shares: All shares of common stock are represented by unvested restricted stock units that will vest in four equal installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| September 28, 2017 Filed Oct 2, 2017 18:40 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,905 | $9.04 | $17,221.20 |
DisclosureSEC source: 0001123292-17-001478 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,095 Read SEC document |
| September 28, 2017 Filed Oct 2, 2017 18:40 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-17-001478 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On September 28, 2017, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 6,000 performance-based restricted stock units, which were converted into 6,000 shares of common stock on a one-for-one basis. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:44 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon stock | 6,295 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209784-17-000040 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,128 F2 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 14, 2018. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. F2 · price: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 14, 2018. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:44 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon stock | 3,284 | $15.13 | $49,678.71 |
DisclosureSEC source: 0001209784-17-000040 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,833 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares. Read SEC document |
| May 05, 2017 Filed May 9, 2017 22:45 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | SaleCommon stock | 44,962 | $14.95 | $672,181.90 |
DisclosureSEC source: 0001209784-17-000032 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,117 Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Exercise / conversionNonqualified stock option · Derivative | 15,000 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001209784-17-000029 · edgar.xml · derivative · entry 3 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 15,000 shares Expires 2018-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Nonqualified stock options granted on February 1, 2008, esting and exercisable on a monthly basis, over the 12 months immediately following the grant date. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | SaleCommon stock | 15,000 | $12.00 | $180,000.00 |
DisclosureSEC source: 0001209784-17-000029 · edgar.xml · nonDerivative · entry 2 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,079 F1 · kind: Sale pursuant to a predetermined sales plan, entered into on February 27, 2015, under Rule 10b5-1 of the Securities and Exchange Act of 1934. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Exercise / conversionCommon stock | 15,000 | $8.06 | $120,825.00 |
DisclosureSEC source: 0001209784-17-000029 · edgar.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.